WAVE Life Sciences Ltd
WVEHealthcare|Biotechnology|Singapore
$6.26
-0.07 (-1.03%)
Tangible Book
$2.66
Upcoming Data Readouts (2)
Sep 2026
Est. completion
P1P2Alpha-1 Antitrypsin Deficiency
A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD
NCT06405633n=24
Dec 2027
Est. completion
P1P2Overweight and Obesity
A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
NCT06842186n=296